News

 

 

BioScience Managers - New Bioscience Innovation Fund to Boost Australian Healthcare Startups

Melbourne, Australia, 3 October, 2016 - Australia’s innovative healthcare and biomedical research sectors are set for a massive boost with the launch of a new venture capital fund.

Read more about BioScience Managers - New Bioscience Innovation Fund to Boost Australian Healthcare Startups

AmpliPhi Biosciences Announces Topline Results from Its Phase 1 Phage Therapy Trial Conducted in the United States

Tuesday, September 13, 2016. Link here.

Read more about AmpliPhi Biosciences Announces Topline Results from Its Phase 1 Phage Therapy Trial Conducted in the United States

AmpliPhi Biosciences’ Bacteriophage Cocktail Shown to Prevent C. difficile Biofilm Formation and Reduce Colonization

Monday, September 12, 2016. Link here.

Read more about AmpliPhi Biosciences’ Bacteriophage Cocktail Shown to Prevent C. difficile Biofilm Formation and Reduce Colonization

ADR - Thomas Lynch appointed as new Adherium chairman

1 September 2016: Link here.

Read more about ADR - Thomas Lynch appointed as new Adherium chairman

Rex Bionics - More Positive Data from RAPPER II

18 August 2016: Link here.

Read more about Rex Bionics - More Positive Data from RAPPER II

Adherium and AstraZeneca Australia Commercial Pilot Program

Melbourne, Australia, 16th August 2016

Read more about Adherium and AstraZeneca Australia Commercial Pilot Program

Rex Bionics - Confirmation of Strategic Investment by Maxhealth

05 August 2016: Rex Bionics plc (AIM: RXB), the pioneer of the REX Robot technology that enhances the mobility of wheelchair users, is today pleased to announce that Maxhealth Medicine Co.

Read more about Rex Bionics - Confirmation of Strategic Investment by Maxhealth

Adherium Build Senior Leadership Team with New Chief Operating Officer and New Head of Corporate Development

Melbourne, Australia, 4 August 2016: Link here.

Read more about Adherium Build Senior Leadership Team with New Chief Operating Officer and New Head of Corporate Development

AmpliPhi Biosciences Completes Enrollment of Its Investigational Phage Therapy Trial Targeting Staphylococcus aureus

Wednesday, August 3, 2016 8:45 am EDT

Read more about AmpliPhi Biosciences Completes Enrollment of Its Investigational Phage Therapy Trial Targeting Staphylococcus aureus

Saluda Medical featured in Nature Journal

Biomedicine: Move over, morphine

Read more about Saluda Medical featured in Nature Journal

1 2 3 4 5 6 ... 22